Originally published on RNZ People desperately seeking cancer treatment which could extend their lives by years, took their battle to increase...
Myeloma NZ
Hundreds rally at Parliament to present petitions for better Pharmac funding
Originally published on NZ Herald Deputy Prime Minister and New Zealand First leader Winston Peter has thrown his weight behind trialling a scheme...
Pharmac chairman backs early access scheme for new drugs
Originally published on NZ Herald Pharmac board chairman Steve Maharey is backing an early access scheme that would give patients access to new and...
Cancer sufferers deliver eight Pharmac funding petitions to Parliament
This story was originally published on RNZ People desperately seeking cancer treatment which could extend their lives by years have called on...
CAR T-Cell Therapy Emerges in Multiple Myeloma
A novel chimeric antigen receptor (CAR) T-cell therapy induced complete and durable responses in a phase I trial involving patients with heavily...
Gene therapy may help fight tough-to-treat blood cancer
A gene therapy that tweaks the immune system might offer hope to people with blood cancer that has resisted standard treatments, a new preliminary...
20k NZers sign petitions for better funding of medicines
Originally published on Te ao Almost 20,000 New Zealanders have signed eight petitions to be presented to parliament, demanding better funding of...
Researchers discover how to prevent kidney damage in patients with multiple myeloma
Researchers at the University of Alabama at Birmingham have discovered a way to prevent kidney failure from occurring in people with multiple...
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing.
The treatment landscape for multiple myeloma has dramatically changed over the past decade with the introduction of several new classes of drugs,...
JOIN THE MARCH
For those who are able to, including family and friends, we urge you to join us on Tuesday 7 May in Wellington to march for the RIGHT TO LIVE. We'll...
Toward personalized treatment in multiple myeloma based on molecular characteristics.
To date, the choice of therapy for an individual multiple myeloma patient has been based on clinical factors such as age and comorbidities. The...
Newsletter: April 2019
Greetings to everyone as the days draw in. We are intending to generate some heat with various planned activities over the next month. There has...